Using the Platelet Function Analyzer-100 for monitoring aspirin therapy
- 31 December 2007
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 120 (2) , 161-172
- https://doi.org/10.1016/j.thromres.2006.08.010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prevalence of aspirin resistance in patients with an evolving acute myocardial infarctionThrombosis Research, 2007
- A Critical Appraisal of the Phenomenon of Aspirin ResistanceCardiology, 2005
- Monitoring Acetylsalicylic Acid Effects with the Platelet Function Analyzer PFA-100Seminars in Thrombosis and Hemostasis, 2005
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunctionJournal of Laboratory and Clinical Medicine, 2001
- Measuring agreement in method comparison studiesStatistical Methods in Medical Research, 1999
- Preliminary Data from a Field Trial of the PFA-100™ SystemSeminars in Thrombosis and Hemostasis, 1995
- Description of an In Vitro Platelet Function Analyzer-PFA-100™Seminars in Thrombosis and Hemostasis, 1995